Completed NA INTERVENTIONAL 2-arm NCT00906295

Establishment of Optimal Transfusion Threshold After Major Orthopedic Surgery

Sponsor: Rigshospitalet, Denmark

Conditions Anemia Arthroplasty Hip Replacement

Interventions Allowed drop in hemoglobin to 4.5-5.5 mmol/L Allowed drop in hemoglobin to level between 5.6-6.5 mmol/L

Updated 5 times since 2017 Last updated: Jun 3, 2011 Started: Jun 30, 2009 Primary completion: May 31, 2011 Completion: Jun 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anemia and Arthroplasty, this trial is completed. The trial is conducted by Rigshospitalet, Denmark and has accumulated 5 data snapshots since 2009. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jun 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rigshospitalet, Denmark
TrygFonden, Denmark

Data source: Rigshospitalet, Denmark

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Copenhagen, Denmark